Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
76
result was found. Results that relate to
Safety
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):690-701.
11384 times
1435 times
ZHANG Bin
LIU Minna
LI Xiaolin
LI Jinhu
LIU Tianlong
National centralized drug procurement
Real world study
Clinical evaluation
Generic drugs
Innovator drugs
Effectiveness
Safety
Details
Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):734-742.
9516 times
1170 times
HU Ruiwen
JI Cheng
LI Li
Diabetic nephropathy
Dapagliflozin
Empagliflozin
Real world study
Efficacy
Safety
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):806-814.
6427 times
927 times
HOU Yibing
KANG Shuo
GONG Yuan
WANG Xiaohui
NIE Ying
LIU Huanlong
Sugemalimab
Non-small cell lung cancer
Effectiveness
Safety
Economics
Rapid health technology assessment
Details
KAP investigation and influential factor analysis on the risk of medication safety behavior among cancer patients in western Yunnan
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(9):1049-1056.
2840 times
681 times
QUE Suyun
MA Qiaoling
ZHOU Xia
CUN Yufang
LI Bin
XU Shidong
MA Xi'na
Medication
safety
Behavioral risk
Knowledge-attitude-behavior
Oncology patients
Factors affecting
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(9):1057-1065.
7544 times
852 times
ZHANG Yunxuan
ZHOU Haifeng
GAO Ningzhou
WU Jianbo
QIAN Cheng
ZHANG Min
GUO Han
SONG Zhongjuan
LIU Xiaoyan
Tirzepatide
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Cost-effectiveness
Details
Qualitative research on nurses' experience and demand for drug identification in the background of centralized procurement
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(10):1178-1187.
2491 times
508 times
YANG Qiao
YANG Jie
Feng Da
Drug identification
Easily confused drug
Medication
safety
Semi-structured interview
Centralized procurement
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(10):1198-1205.
3327 times
585 times
CHEN Lingbin
PAN Weiping
CHEN Zhou
XU Wentan
Inclisiran
Dyslipidemia
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Research on the safety of anesthetic drugs and intervention strategies in neonates and infants
Published on
Frontiers in Pharmaceutical Sciences
2025,29(10):1794-1800.
2387 times
391 times
KE Yanjun
CHEN Jiefeng
PAN Zhengbin
ZHENG Yangjiong
ZHU Qi
Neonatal anesthesia
Developmental neurotoxicity
Drug
safety
Neuroprotection
Intervention strategies
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(11):1302-1310.
1878 times
360 times
YANG Shou
NIE Ying
GONG Yuan
KANG Shuo
HOU Yibing
WANG Xiaohui
PAN Zhenhua
Toripalimab
Advanced esophageal cancer
Rapid health technology assessment
Effectiveness
Safety
Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(11):1311-1319.
1931 times
358 times
LI Zhou
LING Ya
ZHANG Jie
ZHU Ling
Avatrombopag
Primary immune thrombocytopenia
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Meta-analysis of the efficacy and safety of long-term low-dose clarithromycin in the treatment of chronic rhinosinusitis
Published on
New Medicine
2025,35(11):1347-1354.
2332 times
386 times
WANG Yahua
HUANG Chuansheng
ZHANG Zhihui
GUO Xinhong
PENG Xi
Chronic rhinosinusitis
Low-dose clarithromycin
Safety
Efficacy
Meta-analysis
Details
Development and reliability evaluation of a medication safety literacy scale for elderly patients with chronic conditions
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(1):75-82.
1848 times
399 times
WANG Fang
WANG Fengjuan
WANG Wenbo
LIU Huijuan
Medication
safety
literacy
Chronic diseases
Elderly patients
Reliability
Validity
Scale
Details
Rapid health technology assessment of crisaborole in the treatment of mild-to-moderate atopic dermatitis
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1423-1433.
1463 times
284 times
ZHANG Jinfen
TONG Ruofei
YANG Lin
SUN Yanyan
Crisaborole
Atopic dermatitis
Rapid health technology assessment
Efficacy
Safety
Economy
Details
Oliceridine injection for postoperative analgesia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(12):1434-1440.
1204 times
287 times
ZHOU Jing
LUO Hao
ZHENG Xiaoke
CAI Jingyue
XIE Caipeng
TAN Qiuhua
Oliceridine
Postoperative analgesia
Efficacy
Safety
Economy
Rapid health technology assessment
Details
Application progress of paraben preservatives in pharmaceutical preparations
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2145-2153.
1326 times
195 times
YI Qiao
WANG Jie
YAN Leina
Paraben
Antimicrobial effectiveness
Safety
Methylparaben
Ethylparaben
Bacteriostat
Dosage
Details
上一页
1
2
3
4
5
6
下一页